NIMG-22. INTEGRATION OF A RADIOMIC SIGNATURE, CLINICAL VARIABLES AND PLASMA CELL-FREE DNA IN ADULT PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA PREDICTS PATIENT SURVIVAL AND IMPROVES DISEASE STRATIFICATION

PURPOSE: We have previously demonstrated the potential role of liquid biopsy, specifically plasma cell-free DNA (cfDNA), as a non-invasive biomarker for prognostication in patients with glioblastoma. In separate prior studies, we have also developed MRI-based radiomic signatures to predict survival...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Principais autores: Fathi Kazerooni, Anahita, Bashyam, Vishnu, Akbari, Hamed, Sako, Chiharu, Mamourian, Elizabeth, Till, Jacob, Abdalla, Aseel, Yee, Stephanie, Binder, Zev, Nabavizadeh, Seyed Ali, Carpenter, Erica, Davatzikos, Christos, Bagley, Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Neuroimaging
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651207/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.635
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados